Completion of the clinical phase of randomized, double blind, placebo controlled pilot study conducted in India to evaluate safety and efficacy of orally administered IMA001 in sickle cell disease patients.
Imalia Launches Clinical Trial of Oral IMA001 for Sickle Cell Disease in India
Imalia started a multicenter, randomized, double blind, placebo controlled pilot study in India to